Capricor Therapeutics, Inc. (CAPR) Presents at 2026 MDA Clinical & Scientific Conference - Slideshow

Capricor Therapeutics presented at the 2026 MDA Clinical & Scientific Conference, showcasing progress on their investigational therapies. The presentation emphasized developments in their clinical trials and potential immunotherapy applications. Investors may react positively given the increasing interest in innovative treatments for muscular diseases. The focus on cutting-edge science can attract partnerships or funding opportunities. Overall, the event may signal a bullish sentiment for Capricor's future prospects.